Microbiology Spectrum · 2023 · 11 citations · 16 references
PharmacyInfectious DiseasesPharmacokineticsClinical PharmacologyInfectious Disease PharmacotherapyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyViral InfectionsAntiviral Safety AssessmentAntiviral TherapeuticsDirect-acting Antiviral AgentsDirect-acting AntiviralsNegative Predictive Value AssessmentPrimary Outcome AnalysisSars-cov-2 Antiviral TherapyViral Kinetics
activity against SARS-CoV-2. In this study, we evaluated the antiviral activity, safety, efficacy, and pharmacokinetics of bemnifosbuvir in ambulatory patients with mild/moderate COVID-19. In the primary analysis, bemnifosbuvir did not show meaningful antiviral activity compared with placebo as assessed by nasopharyngeal viral loads. The negative predictive value of nasopharyngeal viral load reduction for clinical outcomes in COVID-19 is currently unclear, and further evaluation of bemnifosbuvir for COVID-19 may be warranted despite the findings observed in this study.
16
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk, Tal Gonen, Yaniv Lustig et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Frederick G. Hayden, Norio Sugaya, Nobuo Hirotsu et al. · New England Journal of Medicine · 2018 · 929 citations · Full text